Open AccessDeprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study
Author(s) -
Anne G. R. Visser,
Jos M. G. A. Schols,
Mathieu A. L. M. Prevoo,
R. Janknegt,
Björn Winkens
Publication year - 2021
Publication title -
gerontology and geriatric medicine
Language(s) - English
Resource type - Journals
ISSN - 2333-7214
DOI - 10.1177/23337214211050807
Subject(s) - deprescribing , polypharmacy , medicine , nursing homes , intervention (counseling) , exploratory research , beers criteria , adverse effect , nursing , intensive care medicine , sociology , anthropology
Polypharmacy is common in the frail nursing home population and associated with an increased risk of adverse events, unplanned hospitalizations, and increased all-cause mortality. Deprescribing using a deprescribing algorithm might reduce unnecessary polypharmacy. This exploratory study was performed to determine the effect of this implicit deprescribing algorithm in deprescribing statins and proton pump inhibitors (PPIs) in nursing home residents.Method Multicenter, longitudinal, single-arm exploratory study. All participants received the same deprescribing intervention to identify and deprescribe potentially inappropriate statins and/or PPIs. Residents across 10 nursing homes in the Netherlands were included if they used a statin and/or PPI. Residents in hospices or short-stay wards were excluded. The intervention involved a deprescribing algorithm in which nursing home physicians identified and, if possible, deprescribed potentially inappropriate statins and/or PPIs.Results Sixty-seven residents participated in the study. At 3 months, deprescribing was successful in 52% of the residents. Six months after the intervention, all these residents still had their medication sustainably deprescribed.Conclusion Based on this study, deprescribing statins and PPIs using an implicit deprescribing algorithm is possible in a considerable number of nursing home residents.